In:
Critical Care and Resuscitation, Elsevier BV, Vol. 23, No. 2 ( 2021-6-7), p. 234-238
Abstract:
In 2010, following the publication of two large trials of corticosteroids in septic shock, an international survey of corticosteroid use in the management of septic shock reported marked variability in practice. Two large randomised controlled trials of corticosteroids in septic shock (ie, the ADRENAL trial comparing hydrocortisone v placebo 4 and the APROCCHSS trial comparing hydrocortisone plus fludrocortisone v placebo) published in 2018 reported divergent effects of steroids on mortality at day 90, although important secondary outcomes such as duration of shock and mechanical ventilation were improved in both trials.
Type of Medium:
Online Resource
ISSN:
2652-9335
Uniform Title:
Clinician preferences for prescription of corticosteroids in patients with septic shock: an international survey
Language:
Unknown
Publisher:
Elsevier BV
Publication Date:
2021
Permalink